119 related articles for article (PubMed ID: 34363949)
1. Brefeldin A delivery nanomicelles in hepatocellular carcinoma therapy: Characterization, cytotoxic evaluation in vitro, and antitumor efficiency in vivo.
Zhang JM; Jiang YY; Huang QF; Lu XX; Wang GH; Shao CL; Liu M
Pharmacol Res; 2021 Oct; 172():105800. PubMed ID: 34363949
[TBL] [Abstract][Full Text] [Related]
2. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
Jiang YY; Wu S; Wu YW; Gao Y; Chong D; Sun C; Wei MY; Gu YC; Shao CL; Gu Y
Eur J Med Chem; 2022 Oct; 240():114598. PubMed ID: 35849940
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study.
Tekchandani P; Kurmi BD; Paliwal R; Paliwal SR
AAPS PharmSciTech; 2020 Jun; 21(5):174. PubMed ID: 32548786
[TBL] [Abstract][Full Text] [Related]
4. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy.
Guo Y; Zhang Y; Li J; Zhang Y; Lu Y; Jiang X; He X; Ma H; An S; Jiang C
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5444-53. PubMed ID: 25686400
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and
Wang J; Liu Q; Yang L; Xia X; Zhu R; Chen S; Wang M; Cheng L; Wu X; Wang S
J Biomed Nanotechnol; 2017 Dec; 13(12):1631-1646. PubMed ID: 29490752
[TBL] [Abstract][Full Text] [Related]
6. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice.
Chen X; Hu X; Hu J; Qiu Z; Yuan M; Zheng G
Mol Pharm; 2020 Mar; 17(3):738-747. PubMed ID: 31904241
[TBL] [Abstract][Full Text] [Related]
7.
Huang XF; Sheu GT; Chang KF; Huang YC; Hung PH; Tsai NM
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266043
[TBL] [Abstract][Full Text] [Related]
8. Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line.
Wang W; Xu B; Li Q; Jiang D; Yan S
Mol Med Rep; 2018 Apr; 17(4):6185-6193. PubMed ID: 29484394
[TBL] [Abstract][Full Text] [Related]
9. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma.
Li Y; Wei J; Wei Y; Cheng L; Guo B; Meng F; Li F; Zhong Z
Biomacromolecules; 2020 Feb; 21(2):716-724. PubMed ID: 31809037
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
12. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
13. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Song Q; Tan S; Zhuang X; Guo Y; Zhao Y; Wu T; Ye Q; Si L; Zhang Z
Mol Pharm; 2014 Nov; 11(11):4118-29. PubMed ID: 25222114
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of brefeldin A from electrospun PEG-PLLA nanofibers and their in vitro antitumor activity against HepG2 cells.
Liu W; Wei J; Huo P; Lu Y; Chen Y; Wei Y
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2513-8. PubMed ID: 23623062
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.
Zheng S; Chang S; Lu J; Chen Z; Xie L; Nie Y; He B; Zou S; Gu Z
PLoS One; 2011; 6(6):e21064. PubMed ID: 21695227
[TBL] [Abstract][Full Text] [Related]
18. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
Du Z; Mao Y; Zhang P; Hu J; Fu J; You Q; Yin J
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35518-35532. PubMed ID: 34286569
[TBL] [Abstract][Full Text] [Related]
19. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
20. Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma.
Li D; Liu S; Zhu J; Shen L; Zhang QY; Zhu H
BMC Pharmacol Toxicol; 2021 Jan; 22(1):1. PubMed ID: 33407916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
